rs201719687
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_016134.4(CPQ):c.1delA(p.Met1fs) variant causes a frameshift, start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000152 in 1,568,622 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_016134.4 frameshift, start_lost
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_016134.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CPQ | TSL:1 MANE Select | c.1delA | p.Met1fs | frameshift start_lost | Exon 2 of 8 | ENSP00000220763.5 | Q9Y646 | ||
| CPQ | c.1delA | p.Met1fs | frameshift start_lost | Exon 2 of 9 | ENSP00000630336.1 | ||||
| CPQ | c.1delA | p.Met1fs | frameshift start_lost | Exon 2 of 9 | ENSP00000533877.1 |
Frequencies
GnomAD3 genomes AF: 0.0000804 AC: 12AN: 149252Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000173 AC: 35AN: 202310 AF XY: 0.000155 show subpopulations
GnomAD4 exome AF: 0.000159 AC: 226AN: 1419262Hom.: 0 Cov.: 31 AF XY: 0.000152 AC XY: 107AN XY: 705314 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000803 AC: 12AN: 149360Hom.: 0 Cov.: 32 AF XY: 0.0000687 AC XY: 5AN XY: 72814 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.